DENVER--(BUSINESS WIRE)--AORN Surgical Conference & Expo: Booth 421 -- RF Surgical Systems Inc. (RFS), the market leader in adjunct detection technology for the prevention of retained surgical sponges, today announces the availability of the RF Assure Detection System X, the first integrated solution for the problem of retained surgical sponges. The product is the first in the adjunct detection technology category to incorporate essential compliance support functions as well as improved scanning coverage that extends beyond general surgery to an application-specific approach by surgical specialty. RFS is introducing the product at the Association of periOperative Registered Nurses Surgical Conference & Expo this week and begins shipping units as of April 1, 2015.
Enhancements to the RF Assure Detection System X include a new compliance-driven interface designed to provide “real-time” feedback to guide the OR staff through an effective sponge management protocol. The redesigned interface improves accessibility and data visibility during procedures and automatically stores case and scan records for convenient review and compliance.
In addition, RFS introduces a new scanning component for the RF Assure Detection System X, the The ArQ•Sphere. This new handheld, stationary scanning device leverages dual-3D scan fields to address the positioning challenges specific to extremity, head, neck, spine and other specialty procedures. The ArQ•Sphere offers motion-free scanning with overlapping scan fields, creating an optimal detection zone for orthopedic and specialty procedures.
“The premium digital patient safety platform of the RF Assure Detection System X represents our next generation in market-leading detection technology and innovation from RF Surgical,” said John Buhler, CEO of RF Surgical, Inc. “The integration of a workflow-complementary interface with surgical specialty scanning capabilities significantly advances our efforts to eliminate the risks associated with retained surgical sponges for improved OR patient safety.”
RF Assure technology minimizes the incidence of retained surgical sponges, allowing hospitals to optimize the safety and quality of care for surgical as well as labor and delivery patients. RF Assure uses a reliable, low-energy radio frequency signal specifically designed for the detection of misplaced surgical sponges through blood, dense tissue, and bone. Additional patient-centric benefits realized by the use of adjunct detection technology include reduction in incremental time under anesthesia and the use of x-rays associated with rectifying sponge miscounts. The RF Assure Detection System X is comprised of three complementary components for full OR coverage:
- ConformPlus II Antenna Array Body Scanner: One-touch scanning technology to detect retained sponges in the torso
- Blair-Port Wand X: Handheld, motion-based scanning device for the detection of missing sponges in the surrounding OR environment
- ArQ•Sphere Bi-nodal Scanner: Handheld, stationary scanning device designed with dual-3D scan fields to overcome unique positioning challenges in specialty procedures (extremity and spine)
“The value of adjunct detection technology for the prevention of retained surgical sponges in assuring OR staff confidence and patient safety cannot be overstated,” said Stella Nelson, R.N. and co-author of the seminal clinical study of the efficacy of RF Assure detection technology at the University of North Carolina1. “The thoughtful design and technological improvements in the new RF Assure Detection System X reflect the compliance support needs of OR staff, resulting in important work flow efficiencies.”
About RF Surgical Systems, Inc.
RF Surgical Systems, Inc. is the market leader in the detection and prevention of retained surgical items. The company’s flagship product, the RF Assure® Detection System, is the preferred solution in more than 4,500 OR, trauma, and L&D suites nationwide, including most top ranked U.S. hospitals and trauma centers.
RF Surgical Systems is based in Carlsbad, California. U.S. patents protect the advanced technologies used in the RF Assure Detection System™. Regulatory clearance to market the system was granted by the U.S. Food and Drug Administration in November 2006. Additional information about RF Surgical Systems, Inc. can be found at www.rfsurg.com.
1 Rupp et al. JACS 2012